Literature DB >> 34973842

Bariatric Surgery and Solid-Organ Transplantation.

Amador García Ruiz de Gordejuela1, Ainitze Ibarzabal2, Javier Osorio3.   

Abstract

Morbid obesity and being overweight are a growing problem worldwide. They also affect patients with end-stage solid-organ disease and patients after transplant. Bariatric surgery is the most effective available weight loss procedure. Bariatric surgery can be helpful for the treatment of some conditions, such as nonalcoholic fatty liver disease or nonalcoholic steatohepatitis, which may lead to transplant, and weight loss can improve or even reverse them. In other cases, morbid obesity is a limitation to accessing a transplant program, so bariatric surgery can serve as a conduit to transplant. After transplant, obesity and obesity-related comorbidities can be a significant health problem that may be treated, as in patients without a transplant, with bariatric surgery. There are some specific conditions and issues to be considered in patients with end-stage solid-organ disease who are candidates for bariatric surgery, such as increased morbidity and mortality. After transplant, immunosuppressant regimens and technical limitations may be also significant.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34973842     DOI: 10.1016/j.transproceed.2021.11.008

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  1 in total

1.  Sinomenine promotes differentiation of induced pluripotent stem cells into immature dendritic cells with high induction of immune tolerance.

Authors:  Xiao-Yan Huang; Zhan-Kui Jin; Meng Dou; Bing-Xuan Zheng; Xiang-Rong Zhao; Qing Feng; Yang-Meng Feng; Xiang-Long Duan; Pu-Xun Tian; Cui-Xiang Xu
Journal:  World J Stem Cells       Date:  2022-08-26       Impact factor: 5.247

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.